Dr. Reddy's Laboratories Ltd. closed 21.99% below its 52-week high of 1,420.20 rupees, which the company reached on August ...
Laboratories announced that it is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1 ...
Dr. Reddy’s Laboratories has initiated a voluntary recall of Levetiracetam in 0.75% Sodium Chloride Injection (1,000 mg/100 ...
Dr. Reddy’s Laboratories is recalling a batch of Levetiracetam injection bags in the U.S. due to incorrect labeling, which ...
Dr Reddy’s Laboratories is recalling one batch of Levetiracetam in 0.75 percent Sodium Chloride Injection single-dose ...
Dr. Reddy's Laboratories Ltd. closed 22.18% short of its 52-week high of 1,420.20 rupees, which the company reached on August 21st.
The mislabeling poses a significant health risk, as patients receiving the drug could inadvertently be administered double ...
Dr. Reddy's recalls Levetiracetam infusion bags in the U.S. due to mislabeling, posing risk of serious adverse effects.
Dr. Reddy's Laboratories is recalling one Batch/Lot No: A1540076 of Levetiracetam in 0.75% Sodium Chloride Injection, 1,000 mg/100 mL (10 mg/mL) single-dose infusion bags to the consumer level, in the ...
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
Stay up-to-date with the Dr Reddys Stock Liveblog, your comprehensive source for real-time updates and detailed analysis on a ...
We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results